Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

P2Y 12 Inhibition in Patients Requiring Oral Anticoagulation After Percutaneous Coronary Intervention: The SWAP-AC-2 Study.

Autor: Ortega-Paz L; Division of Cardiology, University of Florida College of Medicine-Jacksonville, Jacksonville, Florida, USA. Electronic address: https://twitter.com/Ortega_Paz., Bor W; St. Antonius Hospital, Nieuwegein, the Netherlands., Franchi F; Division of Cardiology, University of Florida College of Medicine-Jacksonville, Jacksonville, Florida, USA., van den Broek WWA; St. Antonius Hospital, Nieuwegein, the Netherlands., Rollini F; Division of Cardiology, University of Florida College of Medicine-Jacksonville, Jacksonville, Florida, USA., Giordano S; Division of Cardiology, University of Florida College of Medicine-Jacksonville, Jacksonville, Florida, USA., Galli M; Maria Cecilia Hospital, GVM Care & Research, Cotignola, Italy., Been L; Division of Cardiology, University of Florida College of Medicine-Jacksonville, Jacksonville, Florida, USA., Ghanem G; Division of Cardiology, University of Florida College of Medicine-Jacksonville, Jacksonville, Florida, USA., Shalhoub A; Division of Cardiology, University of Florida College of Medicine-Jacksonville, Jacksonville, Florida, USA., Garabedian H; Division of Cardiology, University of Florida College of Medicine-Jacksonville, Jacksonville, Florida, USA., Al Saleh T; Division of Cardiology, University of Florida College of Medicine-Jacksonville, Jacksonville, Florida, USA., Uzunoglu E; Division of Cardiology, University of Florida College of Medicine-Jacksonville, Jacksonville, Florida, USA., Zhou X; Division of Cardiology, University of Florida College of Medicine-Jacksonville, Jacksonville, Florida, USA., Rivas A; Division of Cardiology, University of Florida College of Medicine-Jacksonville, Jacksonville, Florida, USA., Pineda AM; Division of Cardiology, University of Florida College of Medicine-Jacksonville, Jacksonville, Florida, USA., Suryadevara S; Division of Cardiology, University of Florida College of Medicine-Jacksonville, Jacksonville, Florida, USA., Soffer D; Division of Cardiology, University of Florida College of Medicine-Jacksonville, Jacksonville, Florida, USA., Mahowald MK; Division of Cardiology, University of Florida College of Medicine-Jacksonville, Jacksonville, Florida, USA., Choi CY; Division of Cardiology, University of Florida College of Medicine-Jacksonville, Jacksonville, Florida, USA., Zenni MM; Division of Cardiology, University of Florida College of Medicine-Jacksonville, Jacksonville, Florida, USA., Phoenix F; Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom., Ajjan RA; Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom., Ten Berg JM; St. Antonius Hospital, Nieuwegein, the Netherlands., Angiolillo DJ; Division of Cardiology, University of Florida College of Medicine-Jacksonville, Jacksonville, Florida, USA. Electronic address: dominick.angiolillo@jax.ufl.edu.

Publikováno v: JACC. Cardiovascular interventions [JACC Cardiovasc Interv] 2024 Jun 10; Vol. 17 (11), pp. 1356-1370. Date of Electronic Publication: 2024 Apr 07.

Switching from Dual Antiplatelet Therapy with Aspirin Plus a P2Y12 Inhibitor to Dual Pathway Inhibition with Aspirin Plus Vascular-Dose Rivaroxaban: The Switching Anti-Platelet and Anti-Coagulant Therapy (SWAP-AC) Study.

Autor: Ortega-Paz L; Division of Cardiology, University of Florida College of Medicine, Jacksonville, Florida, United States., Franchi F; Division of Cardiology, University of Florida College of Medicine, Jacksonville, Florida, United States., Rollini F; Division of Cardiology, University of Florida College of Medicine, Jacksonville, Florida, United States., Galli M; Division of Cardiology, University of Florida College of Medicine, Jacksonville, Florida, United States.; Departmet of Cardiology, Maria Cecilia Hospital, GVM Care and Research, Cotignola, Italy., Been L; Division of Cardiology, University of Florida College of Medicine, Jacksonville, Florida, United States., Ghanem G; Division of Cardiology, University of Florida College of Medicine, Jacksonville, Florida, United States., Shalhoub A; Division of Cardiology, University of Florida College of Medicine, Jacksonville, Florida, United States., Ossi T; Division of Cardiology, University of Florida College of Medicine, Jacksonville, Florida, United States., Rivas A; Division of Cardiology, University of Florida College of Medicine, Jacksonville, Florida, United States., Zhou X; Division of Cardiology, University of Florida College of Medicine, Jacksonville, Florida, United States., Pineda AM; Division of Cardiology, University of Florida College of Medicine, Jacksonville, Florida, United States., Suryadevara S; Division of Cardiology, University of Florida College of Medicine, Jacksonville, Florida, United States., Soffer D; Division of Cardiology, University of Florida College of Medicine, Jacksonville, Florida, United States., Zenni MM; Division of Cardiology, University of Florida College of Medicine, Jacksonville, Florida, United States., Jennings LK; MLM Medical Labs, LLC, Memphis, Tennessee, United States., Angiolillo DJ; Division of Cardiology, University of Florida College of Medicine, Jacksonville, Florida, United States.

Publikováno v: Thrombosis and haemostasis [Thromb Haemost] 2024 Mar; Vol. 124 (3), pp. 263-273. Date of Electronic Publication: 2023 May 24.

Cangrelor in Patients With Coronary Artery Disease Pretreated With Ticagrelor: The Switching Antiplatelet (SWAP)-5 Study.

Autor: Franchi F; Division of Cardiology, University of Florida College of Medicine - Jacksonville, Jacksonville, Florida, USA., Ortega-Paz L; Division of Cardiology, University of Florida College of Medicine - Jacksonville, Jacksonville, Florida, USA., Rollini F; Division of Cardiology, University of Florida College of Medicine - Jacksonville, Jacksonville, Florida, USA., Galli M; Division of Cardiology, University of Florida College of Medicine - Jacksonville, Jacksonville, Florida, USA; Maria Cecilia Hospital, GVM Care and Research, Cotignola, Italy., Been L; Division of Cardiology, University of Florida College of Medicine - Jacksonville, Jacksonville, Florida, USA., Ghanem G; Division of Cardiology, University of Florida College of Medicine - Jacksonville, Jacksonville, Florida, USA., Shalhoub A; Division of Cardiology, University of Florida College of Medicine - Jacksonville, Jacksonville, Florida, USA., Ossi T; Division of Cardiology, University of Florida College of Medicine - Jacksonville, Jacksonville, Florida, USA., Rivas A; Division of Cardiology, University of Florida College of Medicine - Jacksonville, Jacksonville, Florida, USA., Zhou X; Division of Cardiology, University of Florida College of Medicine - Jacksonville, Jacksonville, Florida, USA., Pineda AM; Division of Cardiology, University of Florida College of Medicine - Jacksonville, Jacksonville, Florida, USA., Suryadevara S; Division of Cardiology, University of Florida College of Medicine - Jacksonville, Jacksonville, Florida, USA., Soffer D; Division of Cardiology, University of Florida College of Medicine - Jacksonville, Jacksonville, Florida, USA., Zenni MM; Division of Cardiology, University of Florida College of Medicine - Jacksonville, Jacksonville, Florida, USA., Reiter B; Clinical Institute of Laboratory Medicine, Medical University of Vienna, Vienna, Austria., Jilma B; Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria., Angiolillo DJ; Division of Cardiology, University of Florida College of Medicine - Jacksonville, Jacksonville, Florida, USA. Electronic address: dominick.angiolillo@jax.ufl.edu.

Publikováno v: JACC. Cardiovascular interventions [JACC Cardiovasc Interv] 2023 Jan 09; Vol. 16 (1), pp. 36-46. Date of Electronic Publication: 2022 Oct 31.